Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP)
L. Jehn (Essen, Germany), J. Wälscher (Essen, Germany), T. Wessendorf (Essen, Germany), E. Livingstone (Essen, Germany), L. Zimmer (Essen, Germany), M. Metzenmacher (Essen, Germany), W. Eberhardt (Essen, Germany), D. Theegarten (Essen, Germany), F. Bonella (Essen, Germany)
Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Jehn (Essen, Germany), J. Wälscher (Essen, Germany), T. Wessendorf (Essen, Germany), E. Livingstone (Essen, Germany), L. Zimmer (Essen, Germany), M. Metzenmacher (Essen, Germany), W. Eberhardt (Essen, Germany), D. Theegarten (Essen, Germany), F. Bonella (Essen, Germany). Bronchoalveolar lavage fluid (BALF) findings in patients with immune checkpoint inhibitor (ICI)-associated interstitial pneumonia (IP). 4240
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: